Pramipex 0.25mg
Available Dosages
| SKU | 812 |
|---|---|
| Generic For | Miraprex |
| Strength | 0.25mg |
| Active Ingredient | Pramipexole |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.30 | US$ 9.09 | |||
|
|||||
| 60 Tablet/s | US$ 0.30 | US$ 18.20 | |||
|
|||||
| 90 Tablet/s | US$ 0.29 | US$ 25.935%US$ 27.30 | |||
|
|||||
Pramipex 0.25mg (Pramipexole) – Affordable Miraprex Alternative
Pramipex 0.25mg is prescribed to treat the signs and symptoms of Parkinson’s disease in adults. It can be used as a monotherapy or in combination with levodopa (another medicine for treating Parkinson’s disease symptoms). It can also be used in treating the symptoms of moderate to severe primary restless leg syndrome (RLS) in adults.
Each Pramipex tablet contains the active ingredient Pramipexole, which stimulates dopamine receptors in the brain. This stimulation of the dopamine receptors triggers nerve impulses in the brain that help control body movements.
Things to take care of while taking the Pramipex 0.25mg
Do not take Pramipex 0.25mg if you are allergic to Pramipexole or any other ingredient in the formulation. The medication is not recommended for use in children or adolescents under the age of 18 years.
Let your healthcare provider know if you have developed any medical conditions, especially any of the following:
- Dyskinesia (abnormal/Uncontrolled movements in the limbs).
- Kidney disease
- If you have reached the advanced stage of Parkinson’s disease and are also consuming levodopa, you might develop dyskinesia while increasing the dose of Pramipexole.
- Psychosis
- Vision impairment
- Dystonia (inability to keep your body and neck straight and upright (axial dystonia)).
- Restless legs augmentation syndrome. If you develop those symptoms, begin earlier than usual in the evening, or if they are more severe or involve larger parts of the affected limbs, your healthcare provider may cause a significant reduction in the dose or stop the treatment.
- Severe heart or blood vessel disorders. In such cases, it is essential to get your blood pressure checked regularly, especially at the beginning of treatment. This helps to avoid postural hypotension (a sudden drop in blood pressure on standing up).
Dosage instructions – Pramipex 0.25mg Pramipexole tablet
You should always take the medicines exactly as your specialist has told you. It is always recommended to follow the dosing schedule provided by your healthcare professional. Generally, Pramipex can be taken before or after consuming food. Be sure to swallow the tablet with a glass of water. If you have a moderate or severe kidney disorder, your healthcare professional will prescribe a lower dose. Moreover, in this case, you will need to take the tablets only once or twice a day. Contact your healthcare professional for the appropriate dosage based on your condition. If you discontinue treatment for a few days and wish to restart, you must restart at the lowest dose. This way, you can build up the dose under the supervision of a healthcare specialist. Your healthcare professional will review your treatment after three months to decide whether to continue it.
Side effects Of Pramipex 0.25mg Pramipexole tablet
You should be aware that all prescription medications carry some risks, and not all possible side effects may be known at this stage. Discuss with your healthcare professional the risk of taking Pramipex 0.25. If you develop any unusual side effects while taking Pramipex, be sure to inform your healthcare specialist. They should be aware of the side effects so that they can identify any unwanted effects and determine the best dose of Pramipexole 0.25mg for you.
Pramipexole may cause side effects such as constipation, nausea, dizziness, memory loss, fatigue, sleepiness, dream abnormalities, weight decrease, restlessness, muscle weakness, pneumonia, aggressive behaviour, headache, hyperkinesia, fainting, visual impairment, vomiting, shortness of breath, peripheral oedema, symptoms of impulse control disorders and compulsions.
Pramipex 0.25mg does not usually interfere with an individual’s activities. However, some individuals may feel sleepy or dizzy while taking this medication, especially during the initial weeks of treatment. If you are taking Pramipexole for restless legs syndrome, you may experience an increase in your symptoms in the early mornings or the afternoon. If this is the case for you, please inform your healthcare specialist.
What is Pramipex 0.25mg used for?
Pramipex 0.25mg contains pramipexole 0.25mg — a non-ergot dopamine agonist (D2/D3 receptor) used for Parkinson's disease and moderate-to-severe restless legs syndrome (RLS). The 0.25mg tablet serves as the starting dose for Parkinson's disease (3 times daily, 0.75mg/day total) allowing gradual receptor adaptation to minimise nausea, dizziness, and orthostatic hypotension. For RLS, a single 0.125mg dose before sleep is typical, with the 0.25mg tablet halved. Pramipexole has greater D3 relative to D2 selectivity compared to ropinirole.
How does pramipexole differ from ropinirole in treating Parkinson's disease?
Both are non-ergot dopamine agonists used for early and adjunct Parkinson's disease therapy. Pramipexole (Pramipex) is a D3-preferring agonist; ropinirole has broader D2/D3 affinity. Clinical trial evidence shows equivalent motor benefit at therapeutic doses. Key practical differences: pramipexole is also approved for moderate-to-severe RLS; their renal clearance profiles differ (pramipexole is largely renally excreted — dose adjustment required in renal impairment). Side effects (somnolence, orthostatic hypotension, impulse control disorders, hallucinations) are similar between agents.
How should Pramipex 0.25mg be dosed for Parkinson's disease?
Initiate pramipexole at 0.125mg TID for 1 week, then 0.25mg TID (week 2). If tolerated, increase by 0.25mg TID each week until adequate motor control. Target dose range: 0.5–1.5mg TID (1.5–4.5mg/day). Take with or without food (food reduces nausea). Take with food if nausea is problematic. Avoid bedtime dose if insomnia is an issue. Do not stop abruptly — taper gradually. For RLS: 0.125–0.5mg once nightly 2–3 hours before bedtime. Renal dose adjustment required: reduce dose by 50% if eGFR 30–50; reduce further or avoid if eGFR <30.
Is Pramipex 0.25mg safe in patients with kidney disease?
Pramipexole is predominantly excreted unchanged by the kidneys — renal impairment significantly increases drug exposure. For mild-to-moderate renal impairment (eGFR 30–50 mL/min), the starting dose should be 0.125mg twice daily (not TID) and maximum dose 1.5mg twice daily. For severe renal impairment (eGFR <30), start at 0.125mg once daily and maximum 1.5mg once daily. Pramipexole is dialysed poorly — dose timing relative to dialysis sessions is less critical than with other renally cleared drugs, but creatinine clearance monitoring remains essential during therapy.
Does Pramipex 0.25mg cause impulse control disorders?
Yes — impulse control disorders (ICDs) are a well-documented dopamine agonist class effect including pramipexole. ICDs include pathological gambling, hypersexuality, binge eating, and compulsive shopping. Pramipexole's D3 receptor affinity (linked to reward pathways) may contribute to its ICD risk. Risk factors include: higher doses, younger age, male sex, personal or family history of addictive behaviour. Screen for ICDs at every visit using direct, non-judgmental questioning. If ICD occurs: reduce dose or switch to levodopa therapy. ICDs typically resolve within weeks of dose reduction.
What interactions affect pramipexole therapy?
Cimetidine inhibits renal pramipexole secretion — increases pramipexole plasma levels by ~50%; reduce pramipexole dose if combination unavoidable. Amantadine and other renal tubular secretion competitors similarly increase pramipexole levels. Antipsychotics (D2 antagonists) directly oppose pramipexole — use dopamine-sparing antipsychotics if needed. CNS depressants (benzodiazepines, opioids, alcohol) enhance somnolence. Metoclopramide and promethazine are antiemetics to avoid — they antagonise dopamine receptors. Domperidone is the safe antiemetic choice during pramipexole initiation.
How does Pramipex 0.25mg compare to Requip (ropinirole) 0.25mg?
Pramipex 0.25mg (pramipexole) and Requip 0.25mg (ropinirole) are both the initial titration dose of their respective non-ergot dopamine agonists for Parkinson's disease. Both provide similar early tolerability testing at the lowest dose. Head-to-head clinical trials show equivalent motor benefit at therapeutic doses. Pramipexole is approximately 3–4 times more potent milligram-for-milligram than ropinirole — so 0.25mg pramipexole TID (0.75mg/day) is the equivalent of ~1mg ropinirole TID (3mg/day). Switching between agents requires dose conversion.
Is Pramipex 0.25mg the same as Mirapex 0.25mg?
Yes. Pramipex 0.25mg and branded Mirapex 0.25mg both contain pramipexole dihydrochloride 0.25mg in bioequivalent immediate-release formulations. Pramipex is the generic alternative providing identical Parkinson's disease and RLS treatment at significantly lower cost — making the multi-week titration process affordable.
Can I order Pramipex 0.25mg from PremiumRxDrugs for delivery to the UK?
Yes. PremiumRxDrugs.com ships Pramipex 0.25mg to the UK, USA, Australia, and many other countries. Our genuine manufacturer-verified Parkinson's and RLS medications, competitive pricing, and free worldwide shipping on qualifying orders make us a dependable source for dopamine agonist therapy.
What side effects should I expect starting Pramipex 0.25mg?
Starting-dose side effects: nausea is most common (typically mild and transient — resolves within 2–4 weeks; take with food); dizziness and orthostatic hypotension (rise slowly, check lying and standing); mild fatigue or somnolence. Monitor for sudden onset sleep — even at 0.25mg TID, sleep attacks are possible. Hallucinations are less common at low doses but can occur in elderly patients even at initiation doses. Begin screening for impulse control disorders from the outset. Report any new psychiatric symptoms, compulsive behaviours, or excessive sleepiness immediately.
Can pramipexole augmentation occur during RLS treatment with Pramipex 0.25mg?
Augmentation — worsening RLS symptoms with long-term dopamine agonist use — occurs in up to 50% of patients using dopamine agonists for RLS over 2–5 years. It manifests as symptoms appearing earlier in the day, spreading to arms, or worsening intensity. The 0.25mg dose is a common RLS dose where augmentation develops. If augmentation occurs: reduce the dose gradually (paradoxically improves augmentation), switch to an alpha-2-delta ligand (pregabalin 150–300mg, gabapentin 1,200–1,800mg), or consider low-dose opioid therapy. Annual augmentation review is essential for all pramipexole RLS patients.
Login
Sign Up
Login
Sign Up